RadNet (RDNT) Net Equity Issued and Repurchased (2023 - 2024)
RadNet's (RDNT) quarterly Net Equity Issued and Repurchased came in at $2000.0 in Q2 2024, down 100.0% year-over-year from $259.2 million in Q3 2023, and down 100.0% quarter-over-quarter from $218.4 million in Q1 2024.
Powered by 
Analysis
RadNet (RDNT) Net Equity Issued and Repurchased (2023 - 2024) Analysis & Trends
RadNet has disclosed Net Equity Issued and Repurchased across 2 years of filings, most recently posting $2000.0 for Q2 2024.
- In Q2 2024, Net Equity Issued and Repurchased fell 100.0% year-over-year to $2000.0; the TTM figure through Mar 2025 stood at $2000.0 (down 100.0% YoY), while the FY2024 annual figure was $218.4 million, down 11.16% from the prior year.
- Net Equity Issued and Repurchased came in at $2000.0 for Q2 2024 at RadNet, down from $218.4 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $259.2 million in Q2 2023 to a low of -$371000.0 in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.63 Bn | 1.16 Bn | - |
| 2 | RadNet | 5.98 Bn | 5.55 Bn | 88.08 Mn | - |
| 3 | Concentra Group Holdings Parent | 4.52 Bn | 4.39 Bn | 192.10 Mn | - |
| 4 | Privia Health | 2.51 Bn | 2.15 Bn | - | - |
| 5 | Pediatrix Medical | 2.11 Bn | 1.70 Bn | - | 1.07 Mn |
| 6 | Progyny | 2.10 Bn | 1.86 Bn | 89.30 Mn | - |
| 7 | Fresenius Medical Care AG | 2.07 Bn | 1.37 Bn | 1.52 Bn | - |
| 8 | Surgery Partners | 1.73 Bn | 2.95 Bn | 622.10 Mn | - |
| 9 | U S Physical Therapy | 1.23 Bn | 1.52 Bn | 41.94 Mn | - |
| 10 | Starling Oncology | 699.26 Mn | 658.17 Mn | 27.17 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 218.38 Mn |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | -371,000.00 |
| Jun 30, 2023 | 259.20 Mn |